Elliott Russell P.
VP Drug Development at Foamix Pharmaceuticals Ltd.
- Sold, on record
- $7k
- Dollars the filings state
- Form 4 sales
- 4
- Latest Oct 1, 2018
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- Foamix Pharmaceuticals Ltd.VP Drug Development
Sales by reason
0
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedMar 2, 2018 2018
Sold 817 shares at $6.14 ($5k)
Elliott Russell P., VP Drug Development
Sold 6% of holdings ($84k position)12,868 shares leftFirst sale on recordFiling
- 2 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedApr 2, 2018 +31 days
Sold 142 shares at $5.08 ($721)
Elliott Russell P., VP Drug Development
Sold 1.1% of holdings ($65k position)12,726 shares leftFiling
- 3 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedJul 2, 2018 +91 days
Sold 142 shares at $5.10 ($724)
Elliott Russell P., VP Drug Development
Sold 1.1% of holdings ($65k position)12,584 shares leftFiling
- 4 Form 4 sale Foamix Pharmaceuticals Ltd.Plan not statedOct 1, 2018 +91 days
Sold 142 shares at $5.81 ($825)
Elliott Russell P., VP Drug Development
Sold 1.1% of holdings ($73k position)12,442 shares left1x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Oct 1, 2018 | Oct 2, 2018 | Foamix Pharmaceuticals Ltd. | VP Drug Development | Form 4 sale | 142 | $825 | 1.1% | Plan not stated | SEC |
| Jul 2, 2018 | Jul 3, 2018 | Foamix Pharmaceuticals Ltd. | VP Drug Development | Form 4 sale | 142 | $724 | 1.1% | Plan not stated | SEC |
| Apr 2, 2018 | Apr 4, 2018 | Foamix Pharmaceuticals Ltd. | VP Drug Development | Form 4 sale | 142 | $721 | 1.1% | Plan not stated | SEC |
| Mar 2, 2018 | Mar 6, 2018 | Foamix Pharmaceuticals Ltd. | VP Drug Development | Form 4 sale | 817 | $5k | 6.0% | Plan not stated | SEC |